1,submitted drug The has hope researchers the already been FDA the Agency Medicines approval available that it could be use patients US 2017 
2,submitted drug The has available could in Europe been FDA both Agency the developed Amgen the be patients US year next approved if soon afterwards the Medicines company 
3,results regulator EU expected is drug looking Agency the deliver to is trial the Medicines verdict its T-Vec year later initial this 
4,lead results The showing jump a length survival could approved T-VEC the dramatic large Laherparepvec Talimogene to be US regulators drug drug 
